Core Viewpoint - The company, Qizheng Tibetan Medicine, has released its 2024 ESG report, highlighting its sustainable strategies and practices in patient care, technological innovation, employee development, cultural heritage, and resource protection, marking the 16th consecutive year of such disclosures [1]. Group 1: Sustainable Supply Chain - Qizheng Tibetan Medicine has established a green sustainable supply chain to ensure the quality and stability of medicinal materials, including the creation of a Tibetan medicinal material database and conducting annual resource surveys [2]. - The company has expanded its base of quality medicinal material production, adding 9 new wild nurturing bases (covering over 80,000 acres) and 9 cooperative bases (covering 1,100 acres) in 2024, with over 50% base rate for 38 products by the end of the reporting period [2]. - Long-term procurement agreements have been signed with local farmers, processing companies, and agricultural cooperatives to create a mutually beneficial supply chain collaboration mechanism [2]. Group 2: Ecological Protection - The company actively conducts research on planting techniques and alternatives for medicinal materials, establishing wild nurturing bases in high-altitude, cold regions, and promoting sustainable harvesting practices [2]. - By the end of 2024, the company has conducted research on 58 varieties of planting techniques, with a total area of various bases focused on wild nurturing reaching 502,450 acres [2]. Group 3: Biodiversity Protection - Biodiversity protection is a key focus area for Qizheng Tibetan Medicine, which is a member of the Business and Biodiversity Coalition and the first Chinese enterprise to respond to the UN Sustainable Development Goal on terrestrial biodiversity [3]. - The company's case on "sustainable development and utilization of Tibetan medicinal resources" has been included in the "Chinese Practices Contributing to Biodiversity" report and was presented at the COP15 event [3].